BDBM798255 US20260078095, Compound Zr-(IIIf)::US20260078095, Example 14

SMILES COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccc(C(=O)N(C)CCCN(C)CCCN(C)C(=S)Nc2ccc(NC(=S)NCCCCCN3O[Zr]ON(C(=O)CCC(=O)NCCCCCN(O)C(C)=O)CCCCCNC(=O)CCC3=O)cc2)cc1C(C)C

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 798255   

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798255BDBM798255(US20260078095, Compound Zr-(IIIf) | US20260078095,...)
Affinity DataIC50: 2.10nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent